Success Stories: EB-1A Approved for Postdoctoral Research Fellow in California in the Field of Molecular Cardiovascular Biology

Client’s Testimonial:

 

Thanks a lot for all the help thus far.
 


On July 25th, 2014, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Research Fellow in the Field of Molecular Cardiovascular Biology (Approval Notice)


General Field: Molecular Cardiovascular Biology

Position at the Time of Case Filing: Postdoctoral Research Fellow

Country of Origin: India

Service Center: Nebraska Service Center (NSC)

State of Residence at the Time of Filing:  California

Approval Notice Date: July 25, 2014

Processing Time: 6 Months, 28 Days

 


Case Summary:

In this case, the client that we had the opportunity to work with was a Postdoctoral Research Fellow from India the field of Molecular Cardiovascular Biology.  She had conducted her research in the highly specialized area of molecular signaling pathways in a variety of pathophysiological conditions of the heart and cardiac cells. Her work had resulted in 12 peer-reviewed scientific articles and 19 presentations at national and international conferences; at the time that her case was filed, her publications had been cited at least 423 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of her work.  She had also reviewed 10 manuscripts for distinctive, internationally-circulated journals.  Her superior level of expertise was confirmed in the following quote from an independent recommender, [Client]  has successfully identified three proteins—Nucleostemin (NS), Pin1, and Centromere associated protein-A (CENP-A)—as essential for cardiac stem cell division, survival, and anti-senescence and are thus useful targets for gene therapy aimed at increasing the effectiveness of stem cell treatment.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that she sought to remain in the United States to continue work in the area of Molecular Cardiovascular Biology, and that her continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, her case was approved in 6 months and 28 days.